Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Galmed Pharmaceuticals Ltd. - Ordinary Shares
(NQ:
GLMD
)
0.7505
-0.0029 (-0.38%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Galmed Pharmaceuticals Ltd. - Ordinary Shares
< Previous
1
2
3
4
Next >
On Tuesday, there are stocks with unusual volume. Let's take a look.
↗
November 18, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
Galmed Pharmaceuticals Stock Snaps 4-Day Losing Streak On Triple-Drug Cancer Breakthrough — Retail Sees Dilution Risks
↗
November 17, 2025
Galmed reported new data showing that its Aramchol–Stivarga–Metformin combination improved tumor cell killing in GI cancer models.
Via
Stocktwits
Topics
Intellectual Property
Regulatory Compliance
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 28, 2025
Via
Benzinga
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
August 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
June 20, 2025
Via
Benzinga
Galmed Pharma Shares Jump 10% On Cancer Drug Data: Retail Traders Turn ‘Extremely Bullish’
↗
May 07, 2025
The company reported that Aramchol, its experimental liver drug, enhanced Regorafenib’s anti-tumor effects without causing toxicity in preclinical models.
Via
Stocktwits
What's going on in today's pre-market session
↗
May 06, 2025
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook
↗
April 28, 2025
Via
Benzinga
Which stocks are gapping on Monday?
↗
April 28, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
These stocks are moving in today's pre-market session
↗
April 28, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
↗
April 28, 2025
Via
Benzinga
Topics
Stocks
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
↗
November 04, 2024
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
↗
October 02, 2024
A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar.
Via
Benzinga
MarketBeat Week in Review – 9/16 - 9/20
September 21, 2024
Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signals
Via
MarketBeat
Topics
Economy
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
↗
September 20, 2024
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.
Via
Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:MRK),(NYSE:PFE),(NASDAQ:GLMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why
↗
September 19, 2024
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares are surging Thursday after the company announced plans to broaden its drug development activities over the next two years.
Via
Benzinga
US Stocks Mixed; General Mills Posts Upbeat Earnings
↗
September 18, 2024
Via
Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
↗
September 18, 2024
Via
Benzinga
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
September 17, 2024
Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.
Via
MarketBeat
Gold Edges Lower; US Homebuilder Sentiment Rises For September
↗
September 17, 2024
Via
Benzinga
Crude Oil Gains Over 1%; US Business Inventories Increase In July
↗
September 17, 2024
Via
Benzinga
Nasdaq Surges 100 Points; US Retail Sales Beat Estimates
↗
September 17, 2024
Via
Benzinga
Topics
Earnings
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
September 17, 2024
Via
Benzinga
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
↗
August 22, 2024
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
